
Loading, please wait...

Loading, please wait...

Managing patients with very severe asymptomatic aortic stenosis surgery often challenges clinicians in daily practice. However, the long-term results from the RECOVERY trial provide compelling evidence for early intervention. This randomized study compared early surgical intervention against conservative care over a ten-year period. Consequently, the findings offer a new perspective on survival benefits for this specific patient group.
Moreover, the study revealed a dramatic reduction in cardiovascular mortality. At the ten-year mark, the cumulative incidence of death was significantly lower in the early-surgery group. Specifically, only 1% of patients in the surgery arm reached the primary endpoint compared to 19% in the conservative-care arm. Therefore, the hazard ratio of 0.10 suggests a massive benefit for those undergoing early procedures.
Furthermore, all-cause mortality also favored the surgical approach. While 32% of patients in the conservative group died within ten years, only 15% of those in the early-surgery group passed away. Because these patients had very severe stenosis, the risk of sudden death remained a constant threat under conservative management. Additionally, early surgery resulted in zero operative mortality, which highlights the safety of modern procedures in low-risk patients.
The trial researchers defined very severe aortic stenosis as an aortic-valve area of 0.75 cm² or less. Additionally, patients needed a peak aortic jet velocity of at least 4.5 meters per second. Although many of these individuals felt healthy, their underlying cardiac risk was clearly high. Because early intervention significantly improves outcomes, clinicians should reconsider the traditional "watchful waiting" strategy for this cohort.
Early surgery significantly reduced the composite of operative or cardiovascular mortality to 1%, compared to 19% in the conservative care group. It also halved the risk of death from any cause.
The study included patients with an aortic-valve area of ≤0.75 cm² and a peak aortic jet velocity of ≥4.5 m/s.
The RECOVERY trial focused on surgical aortic valve replacement (SAVR) in low-risk patients. Clinicians should exercise caution when applying these results to TAVR until further randomized trials are completed.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Kang DH et al. Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years. N Engl J Med. 2026 Mar 26. doi: 10.1056/NEJMoa2511920. PMID: 41880613.
Otto CM, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2021;143:e72–e227.
Vahanian A, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Ten-year data from the RECOVERY trial shows early surgery significantly reduces mortality in asymptomatic patients with very severe aortic stenosis....
6 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today